Pediatric Drug Dosing Reference

GENERAL PEDIATRICS DRUG INFORMATION


Acyclovir

Antiviral


Herpes simplex encephalitis
IV:
3 months-12 years: 10-15 mg/kg (maximum: 1 g/dose) Q8H
>12 years: 10 mg/kg (maximum: 1 g/dose) Q8H

Neonatal HSV
IV:
Treatment: 20 mg/kg Q8H for at least 14 days for skin/ocular/mouth disease (mucous membrane involvement) and a minimum of 21 days for CNS disease.

PO:
Suppressive therapy following Neonatal HSV: 300 mg/m2 TID for 6 months

Varicella (severe) or in immunocompromised
IV:
10 mg/kg (maximum: 1 g/dose) Q8H
Therapy not always indicated in immunocompetent host.

PO:
80 mg/kg/day (maximum: 400 mg/dose) divided 3-5 times daily
Therapy not always indicated in immunocompetent host.

Mucotaneous HSV infection (Mild to moderate)
PO:
30-50 mg/kg/day divided 3-5 times daily

Mucotaneous HSV infection (Severe e.g. eczema herpeticum or immunocompromised hosts)
IV:
5-10 mg/kg Q8H

PO:
Following IV therapy: 60-80 mg/kg/day divided 3-5 times daily

HSV Prophylaxis in selected hematology-oncology patients
PO:
20 mg/kg BID
alternate dosing: 15 mg/kg TID

Chronic suppressive therapy for recurrent mucocutaneous or genital HSV episodes
PO:
15 mg/kg (usual maximum: 400mg/dose) TID

Base dose on ideal body weight. Ensure adequate hydration and urine output (especialy on high dose IV therapy). Monitor kidney function and extend dosing interval to q12h or q24h in renal impairment

Availability: 40 mg/mL oral suspension; tablets as 200 mg and 400 mg.

Pharmacology: Antiviral agent effective against herpes simplex 1 and herpes simplex 2, and varicella. Synthetic nucleoside analogue that inhibits viral DNA synthesis. Largely excreted unchanged by kidney therefore needs dose adjustments in renal failure

Updated: 12/21/2022

Contact Information: This resource is maintained by Mark Duffett (duffett@hhsc.ca), Jon Wong (wongjon@hhsc.ca), and Nicole Clarke (clarken@hhsc.ca)
Disclaimer: This document has been created specifically for Hamilton Health Sciences (HHS) to use for its own patients and the information contained herein may not be applicable or relevant to other health care organizations. This document is for informational purposes only and is not intended to be a substitute for medical or clinical advice from a qualified health care professional. HHS makes no representations or warranties as to the accuracy of the information. This material is current only to the date listed. This material is the intellectual property of HHS and may not be shared, duplicated, or distributed further without the consent of HHS. HHS assumes no liability for the use of this information by the recipient.